RE: These went to 1p for a reason9 Jan 2025 08:17
I don't currently hold so no need to consider my comments a 'defence'.
But that steep fall in early 2024 came after an update which looked like STX were in real danger of requiring the mother of all dilutive equity raises to get back on track. However some clever financial gymnastics managed to get things back on track, firstly by taken an advance on the cash they would eventually receive on the China approval milestone. Taking 50% the total last year instead of waiting years for the full amount was a smart move. They then saw an expansion of their Sallyport facility plus two $10m subscriptions from AOP at 4p and 3p.
If the next trading update shows further operation progress, say $50k+ prescriptions at $225 net, then STX might just pull off the recovery, against all odds.
I'd buy back in on any further share price weakness.